A. Ottobrelli

Mucosal healing in inflammatory bowel diseases: a systematic review

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Bone Marrow Stem Cells Contribute to Alcohol Liver Fibrosis in Humans

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study

Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group

Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial

Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination

Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: A pilot study

Lamivudine for chronic delta hepatitis

Infliximab for acute, not steroid-refractory ulcerative colitis

Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma

Acute kidney injury

A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis

Hepatitis C and liver transplantation

The effect  of  1  month  of  therapy with midodrine, octreotide‐LAR and albumin in refractory ascites: a pilot study

Hepatitis D virus: an update

Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation

Burden of liver diseases in the world

Hepatitis B and Hepatitis C Viruses in Liver Transplantation

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels

Pathogenesis of Hepatorenal Syndrome: Implications for Therapy

Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative Colitis

Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study

Intensive Care Unit Management of Patients with Liver Failure

Inflammatory bowel disease: clinical aspects and established and evolving therapies

Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

Updated Clinical Classification of Pulmonary Hypertension

Renal Failure in Cirrhosis

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up

The evolution of free radicals and oxidative stress

Acute Kidney Injury: New Concepts

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis

Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

Nitric Oxide and Peroxynitrite in Health and Disease

Intravenous Cyclosporin in Ulcerative Colitis: A Five-Year Experience

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta

Management of Hepatocellular Carcinoma *

Liver transplantation for chronic viral hepatitis

Prevention and treatment of hepatitis C virus recurrence after liver transplantation

Terlipressin for hepatorenal syndrome

Acute kidney injury

A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo

Ulcerative colitis

Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness

Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted

Combined treatment with pegylated interferon (α-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation

Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells

Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro

Treating hepatitis C

Chronic hepatitis B

Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study

Chronic hepatitis B: Update 2009 #

Updated Clinical Classification of Pulmonary Hypertension

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.

Medical therapy for ulcerative colitis 2004

Hepatorenal Disorders

Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure

Treatment of hepatitis C

Systematic Review of Randomized Trials on Vasoconstrictor Drugs for Hepatorenal Syndrome

Hepatitis Delta virus, a model of liver cell pathology

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

Pulmonary–Hepatic vascular Disorders (PHD)

Inflammatory Bowel Disease

Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome

Acute kidney injury in cirrhosis

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice

Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes

The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets

The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Granulocyte‐colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis

Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study

An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response

Inflammatory bowel disease: Etiology and pathogenesis

Recurrent hepatitis C genotype 1b following liver transplantation

Infection in Solid-Organ Transplant Recipients

Predictors of Response to Therapy With Terlipressin and Albumin in Patients With Cirrhosis and Type 1 Hepatorenal Syndrome

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Pulmonary Arterial Hypertension in France

Comparison of the Effect of Adenoviral Delivery of Three Superoxide Dismutase Genes Against Hepatic Ischemia-Reperfusion Injury

A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

Flying Under the Radar: The Immunobiology of Hepatitis C

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Infections in solid-organ transplant recipients

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes

Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

Terlipressin in Hepatorenal Syndrome

Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles

Meta‐analysis: antiviral treatment for hepatitis D

COBAS AmpliPrep-COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real-Time PCR Assay for Quantification of HBV DNA in Plasma

Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D

Aspergillus fumigatusand Aspergillosis

The Role of Oxidative Stress and Antioxidants in Liver Diseases

Terlipressin versus other vasoactive drugs for hepatorenal syndrome

A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis

Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents

LIVER TRANSPLANTATION FOR CHRONIC VIRAL HEPATITIS

Towards a small animal model for hepatitis C

A critical review of cyclosporine therapy in inflammatory bowel disease

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Chronic Viral Hepatitis and Hepatocellular Carcinoma

Patterns of hepatitis delta virus reinfection and disease in liver transplantation

Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin

Recurrence of hepatitis D (delta) in liver transplants: Histopathological aspects

Hepatitis type C after ortothopic liver transplantation: reinfection and disease recurrence

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease

Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study

Continuously Infused Cyclosporine at Low Dose Is Sufficient to Avoid Emergency Colectomy in Acute Attacks of Ulcerative Colitis Without the Need for High-Dose Steroids

The first one thousand liver transplants in Turin: a single-center experience in Italy

Smoking and Hypoxemia Caused by Hepatopulmonary Syndrome Before and After Liver Transplantation

Oxidative damage in human liver transplantation

Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study.

203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized study

Patterns of HDV reinfection in liver transplantation

Hepatitis delta virus infection and disease; the lesson from the liver transplantation model.